Jan 18 (Reuters) - venBio Select Advisor LLC:
* venBio sends letter to Immunomedics stockholders
* Beneficial owner of about 10.5 million shares, or 9.9%, of Immunomedics Inc and its largest stockholder
* Have proposed slate of four nominees to Immunomedics ' management in specific areas needed to effect change at Immunomedics
* "There is no evidence that changes at board level would delay approvals for IMMU-132"
* While we discussed Immunomedics informally with Jason Aryeh prior to deciding to take action at co, never offered Aryeh position on slate of nominees Source text for Eikon: Further company coverage: